- About Us
- Nano-Social Network
- Nano Consulting
- My Account
February 1st, 2005
"We have demonstrated the first diagnostic test for the potential Alzheimer's biomarker known as an ADDL," said Chad Mirkin, director of Northwestern's Institute for Nanotechnology. "This protein is only 5 nm wide and present in cerebrospinal fluid at very low concentration, making it difficult to detect. Our bio-barcode-amplification technology, which is a million times more sensitive than any other diagnostic technology, can accurately identify ADDLs even in CSF."
The bio-barcode-amplification technique uses 30 nm-diameter gold nanoparticles and magnetic microparticles.
|Related News Press|
Tiny nanoclusters could solve big problems for lithium-ion batteries February 21st, 2017
Breakthrough with a chain of gold atoms: In the field of nanoscience, an international team of physicists with participants from Konstanz has achieved a breakthrough in understanding heat transport February 20th, 2017
In-cell molecular sieve from protein crystal February 14th, 2017
Cedars-Sinai, UCLA Scientists Use New ‘Blood Biopsies’ With Experimental Device to Speed Cancer Diagnosis and Predict Disease Spread: Leading-Edge Research Is Part of National Cancer Moonshot Initiative February 13th, 2017
GLOBALFOUNDRIES Announces Availability of 45nm RF SOI to Advance 5G Mobile Communications: Optimized RF features deliver high-performance solutions for mmWave beam forming applications in 5G smartphones and base stations February 22nd, 2017
Molecular phenomenon discovered by advanced NMR facility: Cutting edge technology has shown a molecule self-assembling into different forms when passing between solution state to solid state, and back again - a curious phenomenon in science - says research by the University of Wa February 22nd, 2017